Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Sarepta Therapeutics, Inc. | Director | Common Stock | 2.93M | $367M | $125.34 | Mar 1, 2024 | Direct |
Sarepta Therapeutics, Inc. | Director | Common Stock | 240K | $30.1M | $125.34 | Mar 1, 2024 | By Trust |
CASSAVA SCIENCES INC | President & CEO, Director | Common Stock | 470K | $10.3M | $22.00 | Apr 23, 2024 | By Trust |
CASSAVA SCIENCES INC | President & CEO, Director | Stock Option (Right to Buy) | 600K | $10.1M | $16.87 | Oct 1, 2024 | Direct |
Sarepta Therapeutics, Inc. | Director | Common Stock | 10K | $1.25M | $125.34 | Mar 1, 2024 | By LLC |
Sarepta Therapeutics, Inc. | Director | Stock Option (right to buy) | 3.68K | Mar 1, 2024 | Direct | ||
CASSAVA SCIENCES INC | President & CEO, Director | Common Stock Warrant | 0 | Apr 23, 2024 | By Trust |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SAVA | CASSAVA SCIENCES INC | Oct 1, 2024 | 1 | $0 | 4 | Oct 1, 2024 | President & CEO, Director |
SAVA | CASSAVA SCIENCES INC | May 9, 2024 | 1 | $0 | 4 | May 13, 2024 | Director |
SAVA | CASSAVA SCIENCES INC | Apr 23, 2024 | 3 | $3.87M | 4 | Apr 25, 2024 | Director |
SRPT | Sarepta Therapeutics, Inc. | Mar 1, 2024 | 2 | $0 | 4 | Mar 5, 2024 | Director |
SRPT | Sarepta Therapeutics, Inc. | Nov 3, 2023 | 2 | $3.94M | 4 | Nov 6, 2023 | Director |
SAVA | CASSAVA SCIENCES INC | Aug 21, 2023 | 2 | $308K | 4 | Aug 23, 2023 | Director |
SAVA | CASSAVA SCIENCES INC | May 4, 2023 | 2 | $559K | 4 | May 8, 2023 | Director |
SRPT | Sarepta Therapeutics, Inc. | Mar 6, 2023 | 2 | $0 | 4 | Mar 8, 2023 | Director |
SAVA | CASSAVA SCIENCES INC | Mar 6, 2023 | 2 | $2.29M | 4 | Mar 8, 2023 | Director |
SAVA | CASSAVA SCIENCES INC | Aug 23, 2022 | 1 | $860K | 4 | Aug 25, 2022 | Director |
SRPT | Sarepta Therapeutics, Inc. | Mar 7, 2022 | 2 | $0 | 4 | Mar 8, 2022 | Director |
SAVA | CASSAVA SCIENCES INC | Jun 11, 2021 | 0 | $0 | 3 | Jun 14, 2021 | Director |